In December 2025, the World Health Organization recommended the long-term use of GLP-1 drugs along with intensive behavioral therapy for people living with obesity
Medicaid Coverage Framework: Key Variables Affecting Approval Decisions Multiple clinical and administrative factors determine whether your state Medicaid plan will authorize GLP-1 therapy
Among the type 2 diabetes segment, Novo Nordisks Ozempic (semaglutide) sub-segment held the largest revenue, whereas Eli Lillys Mounjaro (tirzepatide) sub-segment expected to register the fastest double-digit growth rate during the forecast period
J Neurosci (2008) 28:372937
Peptide Therapy can be administered through injections, nasal sprays, or other delivery methods depending on the compound
In addition, the cost-effectiveness of semaglutide 2.4 mg was examined among subgroup populations, including patients with BMI 30 and BMI 35 (Supplementary Tables S22, S23, S24, S25)